Current status of the taxanes as adjuvant therapy for breast cancer

Clifford Hudis; Heather McArthur; Chau Dang

doi:10.1016/j.breast.2007.07.022

Current status of the taxanes as adjuvant therapy for breast cancer

Clifford Hudis, Heather McArthur, Chau Dang

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Adjuvant chemotherapy for breast cancer reduces the risks of recurrence and death in many subsets of patients. The quest for better regimens, defined as both more effective and less toxic has led to numerous clinical trials testing the taxanes in the adjuvant setting. These trials are generally positive but do not clearly identify a single best or ideal regimen for all patients. This paper reviews the available data in this area of clinical research.

Original language	English (US)
Pages (from-to)	132-135
Number of pages	4
Journal	Breast
Volume	16
Issue number	2 SUPPL.
DOIs	https://doi.org/10.1016/j.breast.2007.07.022
State	Published - 2007
Externally published	Yes

Keywords

Adjuvant therapy
Breast cancer
Taxanes

ASJC Scopus subject areas

Surgery
Oncology
Cancer Research

Access to Document

10.1016/j.breast.2007.07.022

Cite this

@article{da697443a49b47179efbd75ccc9be621,

title = "Current status of the taxanes as adjuvant therapy for breast cancer",

abstract = "Adjuvant chemotherapy for breast cancer reduces the risks of recurrence and death in many subsets of patients. The quest for better regimens, defined as both more effective and less toxic has led to numerous clinical trials testing the taxanes in the adjuvant setting. These trials are generally positive but do not clearly identify a single best or ideal regimen for all patients. This paper reviews the available data in this area of clinical research.",

keywords = "Adjuvant therapy, Breast cancer, Taxanes",

author = "Clifford Hudis and Heather McArthur and Chau Dang",

year = "2007",

doi = "10.1016/j.breast.2007.07.022",

language = "English (US)",

volume = "16",

pages = "132--135",

journal = "Breast",

issn = "0960-9776",

publisher = "Churchill Livingstone",

number = "2 SUPPL.",

}

TY - JOUR

T1 - Current status of the taxanes as adjuvant therapy for breast cancer

AU - Hudis, Clifford

AU - McArthur, Heather

AU - Dang, Chau

PY - 2007

Y1 - 2007

N2 - Adjuvant chemotherapy for breast cancer reduces the risks of recurrence and death in many subsets of patients. The quest for better regimens, defined as both more effective and less toxic has led to numerous clinical trials testing the taxanes in the adjuvant setting. These trials are generally positive but do not clearly identify a single best or ideal regimen for all patients. This paper reviews the available data in this area of clinical research.

AB - Adjuvant chemotherapy for breast cancer reduces the risks of recurrence and death in many subsets of patients. The quest for better regimens, defined as both more effective and less toxic has led to numerous clinical trials testing the taxanes in the adjuvant setting. These trials are generally positive but do not clearly identify a single best or ideal regimen for all patients. This paper reviews the available data in this area of clinical research.

KW - Adjuvant therapy

KW - Breast cancer

KW - Taxanes

UR - http://www.scopus.com/inward/record.url?scp=35648963027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35648963027&partnerID=8YFLogxK

U2 - 10.1016/j.breast.2007.07.022

DO - 10.1016/j.breast.2007.07.022

M3 - Article

C2 - 17723302

AN - SCOPUS:35648963027

SN - 0960-9776

VL - 16

SP - 132

EP - 135

JO - Breast

JF - Breast

IS - 2 SUPPL.

ER -

Current status of the taxanes as adjuvant therapy for breast cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this